arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up

BiomX Inc.

PHGE Health Care Biotechnology: Biological Products (No Diagnostic Substances)
$1.85
▲ +14.2% Today
as of Oct 22, 16:51 ET
Last 30 days -44.79% Sep 24 → Oct 08
$0.27 $0.34 $0.41 $0.48 $0.55 Sep 24 Sep 28 Sep 30 Oct 02 Oct 06 Oct 08
Open
$0.69
High
$2.16
Low
$1.65
Volume
$3M
Avg Vol
$2M
Mkt Cap
$4M
P/E (TTM)
0.23
Beta
—
52w High
$2.16
52w Low
$0.26
Div Yield
—
Shares Out
$13M

Recent Press Releases & News last 60 days · 2 items

PHGE earnings at a glance

Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±31.4% on average; after the most recent report on May 20, 2026 it moved +59.6%. PHGE beat the consensus EPS estimate in 2 of its last 2 reported quarters. The share price of $1.85 sits near its 52-week high.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$0.26
$2.16
84% of range
Avg surprise (last 2)
+89.5%
Avg reaction (last 2)
+31.4%
100% positive

Earnings trends

EPS — actual vs estimate Actual Estimate
$-0.42$0.38$1.18$1.98$2.78 Actual $0.20Actual $0.12Actual $1.30Actual $2.78Actual $0.69Actual $-0.31Actual $-0.33Est $-0.42Actual $0.19Est $-0.33Actual $0.29Actual $0.03Actual $0.37 MarJunSepMarJunSepMar/2025Jun/2025SepMar/2026Jun
Revenue vs Net Income Revenue Net income
$-19M$-12M$-5M$3M$10M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $0.37 — — — — financials
Wed May 20, 2026Mar/2026 $0.03 — — +109.1% +59.6% earnings
Tue Sep 30, 2025Sep 2025 $0.29 — — — — financials
Wed Aug 13, 2025Jun/2025 $0.19 $-0.33 +157.6% — — earnings
Thu May 15, 2025Mar/2025 $-0.33 $-0.42 +21.4% — +3.1% earnings
Mon Sep 30, 2024Sep 2024 $-0.31 — — — — financials
Sun Jun 30, 2024Jun 2024 $0.69 — — — — financials
Sun Mar 31, 2024Mar 2024 $2.78 — — — — financials
Sat Sep 30, 2023Sep 2023 $1.30 — — — — financials
Fri Jun 30, 2023Jun 2023 $0.12 — — — — financials
Fri Mar 31, 2023Mar 2023 $0.20 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$332,000———————
Cost of revenue$235,000———————
Gross profit$97,000———————
Operating income$-5M$-1M—$-9M$-7M$-8M—$-11M
Net income$-4M$-19M—$-9M$-6M$-8M—$10M
EPS (diluted)$0.37$7.38—$0.29$3.66$6.27—$-0.31

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$347,000$1M$4M$7M$14M$20M$17M$24M
Inventory————————
Total current assets$2M$3M$6M$9M$17M$24M$21M$28M
Total assets$28M$3M$6M$26M$38M$46M$43M$60M
Long-term debt$247,000———————
Total liabilities$11M$4M$7M—————
Total equity$11M$-881,000$-1M$10M$19M$24M$24M$38M

Implied volatility — last 90 days

No IV snapshots yet for PHGE.

IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.

Sector peers

PHGE earnings FAQ

How does PHGE stock usually react to earnings?

Across the last 2 reports the average next-day move was ±31.4%, up 2 times and down 0 times.

🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.